Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rATG vs rATG + IVIG in HLA Incompatible Kidney Transplant
NCT04302805Phase 3Completed
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Jul 2020
- Primary completion
- Apr 2024
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of polyvalent human immunoglobulin in kidney transplantation, sponsored by Institute for Clinical and Experimental Medicine. Started Jul 2020; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT04302805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04302805.